The Deal at a Glance

Rem3dy Health, the Birmingham-based company behind the personalized vitamin gummy brand Nourished, has closed a $19 million growth funding round at a post-money valuation of approximately $112 million. The round brings the company's cumulative capital raised to roughly $33 million across multiple rounds since its founding in 2019, and follows a year of accelerating commercial traction for its 3D-printed, seven-layer nutrient "stacks."

The company reported 2025 revenue of $13.6 million, alongside gross margins of 55%—a notable improvement for a manufacturing-intensive consumer health brand. Crucially, the operating loss narrowed sharply to $1.3 million in 2025, down from $5 million the prior year, signaling a business approaching the inflection point between scaling losses and sustainable unit economics.

Key Takeaways

  • Rem3dy Health raised $19 million at a $112 million valuation, with backing from Suntory Global Spirits, Estrella Galicia, and other strategic and institutional investors.
  • 2025 revenue reached $13.6 million with 55% gross margins, while the operating loss narrowed from $5 million in 2024 to $1.3 million in 2025—a near-fourfold improvement.
  • The company's core innovation is patented 3D-printing technology that produces seven-layer, personalized vegan gummy "stacks" tailored to individual health profiles.
  • Strategic investors—particularly beverage and wellness conglomerates like Suntory—signal growing corporate interest in personalized nutrition as a platform for category expansion.
  • For the MENA region, the deal underscores rising investor appetite for functional nutrition formats that align with the Gulf's fast-growing wellness and longevity consumer segment.

From Niche Manufacturing Innovation to Scaled Consumer Brand

Rem3dy Health was founded in 2019 by Melissa Snover, a registered nutritionist whose frustration with carrying multiple vitamin bottles while travelling led her to develop a 3D-printing process capable of combining several nutrients into a single, customized gummy. The resulting product—marketed under the Nourished brand—consists of seven distinct layers, each formulated according to a customer's responses to an online health questionnaire covering goals, diet, and lifestyle factors.

The model has scaled meaningfully. The company operates three production facilities in the UK, holds dozens of granted patents covering its additive manufacturing and dosing processes, and distributes through major retailers including Boots and Holland & Barrett, as well as thousands of pharmacies across continental Europe. Daily production volumes now run into the hundreds of thousands of personalized gummy units.

$13.6M
2025 Revenue
55%
Gross Margin
$1.3M
2025 Operating Loss (vs. $5M in 2024)
3
UK Production Facilities

Why Strategic Investors Are Backing Personalized Nutrition

The investor roster behind this round is notable less for its size than for its composition. Suntory Global Spirits, the international arm of the Japanese beverage and wellness conglomerate, and Estrella Galicia, the Spanish brewing group, both participated—alongside other institutional backers. For large beverage and consumer health companies, minority stakes in personalized nutrition platforms offer a low-risk entry point into a category growing far faster than their core businesses, while providing access to manufacturing technology and direct-to-consumer data that would be costly to build internally.

This pattern echoes a broader trend across the food and ingredients sector, where established conglomerates increasingly prefer strategic minority investments and ingredient partnerships over outright acquisitions when entering adjacent, fast-growing categories such as functional nutrition, longevity, and personalized wellness.

Operating losses narrowing from $5 million to $1.3 million in a single year—while revenue and gross margin both improved—is the kind of efficiency trajectory that distinguishes durable consumer health platforms from venture-funded experiments.

Saudi FoodTech Editorial Analysis

The Personalized Nutrition Market Backdrop

Rem3dy Health's raise lands amid sustained growth in the global personalized nutrition market, which various industry estimates place in the range of $15–18 billion as of 2025–2026, with compound annual growth rates commonly cited between 12% and 14.5% through the early 2030s. Growth drivers include rising consumer interest in preventive health, the mainstreaming of biomarker-driven supplementation, and—more recently—a wave of interest in metabolic health linked to the broader uptake of GLP-1 medications, which has heightened demand for complementary nutrient support products.

Within this landscape, 3D-printed and additive-manufactured nutrition remains a small but fast-growing niche, distinguished by its ability to deliver true per-unit personalization at commercial scale—a capability traditional tablet and capsule manufacturing struggles to replicate economically. Rem3dy's patent portfolio in this space represents a meaningful technical moat as larger players, including global ingredients and nutrition companies, explore entry into personalized formats through partnerships rather than building competing manufacturing capability from scratch.

Relevance to Saudi Arabia and the MENA Region

For the Gulf region, this transaction is relevant on two fronts. First, the personalized and functional nutrition category aligns closely with consumer trends already visible across Saudi Arabia and the UAE, where rising health consciousness, growing gym and wellness culture, and increasing disposable income are driving demand for premium, science-backed supplement formats—particularly among younger, urban consumers.

Second, the involvement of large strategic investors such as Suntory in a personalized nutrition platform reinforces a model that Saudi and Gulf-based investors have shown growing interest in: backing capital-efficient, technology-differentiated nutrition brands with a credible path to international expansion, including into MENA markets. As regional retailers and pharmacy chains continue to expand their wellness and supplement categories, brands with proprietary manufacturing technology and demonstrated retail distribution in Europe—such as Nourished—represent the kind of partner profile increasingly sought by Gulf distributors and investors looking to capture the personalized health and longevity opportunity domestically.


Editorial View

This raise is best read as a validation round rather than a pure growth-capital event. At $13.6 million in revenue and a $112 million valuation, Rem3dy Health is being valued on the strength of its technology platform, patent position, and improving unit economics rather than on current scale alone. The near-fourfold reduction in operating losses—from $5 million to $1.3 million—within a single year is the more telling data point: it suggests the underlying manufacturing and distribution model is approaching the efficiency thresholds that typically precede profitability in consumer health businesses.

For operators and investors tracking the MENA food and wellness sector, the broader signal is that personalized nutrition is transitioning from a venture-backed novelty into a category attracting serious strategic capital from established beverage and consumer health groups. Brands that can combine defensible manufacturing technology with improving margins—rather than relying purely on subscription growth—are likely to be the ones that set the template for international expansion, including into the Gulf's rapidly developing wellness retail landscape.